Enforcement, Earnings, Employment: Health And Wellness Industry News

Prison sentence in DMAA supplement case; Abbott Nutrition flat on currency exchange; Lurie takes CSPI helm; and more news in brief.

Another defendant is sentenced to prison following an FDA investigation of businesses marketing products labeled as dietary supplements but spiked with drugs. Derek Vest, of Fort Myers, Fla., on July 17 received an 18-month sentence ordered to forfeit $2.5m in proceeds from sales of more than 2m DMAA-spiked supplements by his firm, Gentech Pharmaceutical LLC, from April 2013 through November 2014, according to the US Attorney for the Middle Florida District. Vest authorized the use of 1,3 dimethylamylamine as an undisclosed ingredient in Gentech products AddTabz, marketed as an alternative to drugs indicated for heightening mental focus, and PhenTabz and PhenTabz-Teen promoted for weight loss. Vest, who pleaded guilty in March, goes to prison a month after Sitesh Patel, former vice president of S.K. Laboratories Inc., received an eight-month sentence for convictions in Virginia federal court on charges linked to manufacturing DMAA-spiked supplements, and six months before Patel, [USPlabs LLC] and its executives are scheduled to face trial in Texas also on charges stemming the use of DMAA in supplements. (Also see "S.K. Labs VP Imprisoned Before Trial On Charges Linked To USPlabs" - HBW Insight, 21 June, 2017.)

More from Innovation & IP

More from Wellness